Non-invasive Vagus Nerve Stimulation (nVNS) and Cognition in Young Adult Vapers - A Pilot Study
ConditionVaping
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-25
SponsorTemple University
About this trial
The purpose of this study is to assess the effects of non-invasive vagus nerve stimulation (nNVS) on cognitive functioning in the users of e-cigarettes or vaping products. The investigators will use a digital wellness companion product (TRUVAGA™ device) that provides mild transcutaneous nVNS. The participants will be randomized to receive either a 2-min nNVS stimulation or control stimulation in the neck region followed by completion of three cognitive tests of attention and executive function.
Eligibility criteria
Qualifiers
Healthy young adults
Age range 18-25 years
Current or prior users of e-cigarettes
Disqualifiers
Have any rash, infection, swelling, cut, soreness, drug patch, surgical scar on the neck area
Have any implantable medical device in their body such as a pacemaker, hearing aid implant, or any other metallic/electronic device
Have any hearing or vision problems that are not corrected
Are pregnant or breastfeeding
Trial design
Treatments tested in this trial
- Active nVNS
- Control nVNS
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov